Nov 12, 2019

TCR² Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Oct 09, 2019

TCR² Therapeutics Appoints Industry Veteran Angela Justice, Ph.D., as Chief People Officer

Sep 27, 2019

TCR² Therapeutics to Present at the Cantor Global Healthcare Conference

Aug 30, 2019

TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference

Aug 08, 2019

TCR² Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 06, 2019

TCR² Therapeutics to Participate in Upcoming Conferences in August

Aug 06, 2019

TCR² Therapeutics Deepens Manufacturing and Immuno-Oncology Expertise with Key Hires

Jul 31, 2019

TCR² Therapeutics Announces Partnership with the National Cancer Institute for Phase 1/2 Trial of TC-210

Jun 28, 2019

TCR² Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

May 13, 2019

TCR² Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update